PL2431360T3 - Pochodne dihydrobenzoksatiazepiny, sposób ich wytwarzania i kompozycje farmaceutyczne, które je zawierają, jak również zastosowanie tych związków jako modulatorów receptorów AMPA - Google Patents

Pochodne dihydrobenzoksatiazepiny, sposób ich wytwarzania i kompozycje farmaceutyczne, które je zawierają, jak również zastosowanie tych związków jako modulatorów receptorów AMPA

Info

Publication number: PL2431360T3
Authority: PL; Poland
Prior art keywords: dihydrobenzoxathiazepine; modulators; derivatives; well; pharmaceutical compositions
Prior art date: 2010-09-16

Application number

PL11290413T

Other languages

English (en)

Inventor

Alexis Cordi

Patrice Desos

Pierre Lestage

Laurence Danober

Original Assignee

Servier Lab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2010-09-16

Filing date

2011-09-15

Publication date

2013-08-30

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43067253&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2431360(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2011-09-15 Application filed by Servier Lab filed Critical Servier Lab

2013-08-30 Publication of PL2431360T3 publication Critical patent/PL2431360T3/pl

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D291/00—Heterocyclic compounds containing rings having nitrogen, oxygen and sulfur atoms as the only ring hetero atoms
- C07D291/08—Heterocyclic compounds containing rings having nitrogen, oxygen and sulfur atoms as the only ring hetero atoms condensed with carbocyclic rings or ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/554—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D419/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms
- C07D419/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D419/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Psychology (AREA)
Epidemiology (AREA)
Hospice & Palliative Care (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
Thiazole And Isothizaole Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

PL11290413T 2010-09-16 2011-09-15 Pochodne dihydrobenzoksatiazepiny, sposób ich wytwarzania i kompozycje farmaceutyczne, które je zawierają, jak również zastosowanie tych związków jako modulatorów receptorów AMPA PL2431360T3 (pl)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR1003683A FR2964969B1 (fr)	2010-09-16	2010-09-16	Nouveaux derives dihydrobenzoxathiazepines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
EP11290413.1A EP2431360B1 (fr)	2010-09-16	2011-09-15	Derives de dihydrobenzoxathiazepines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent ainsi que leur utilisation comme modulateurs des recepteurs AMPA

Publications (1)

Publication Number	Publication Date
PL2431360T3 true PL2431360T3 (pl)	2013-08-30

Family

ID=43067253

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL11290413T PL2431360T3 (pl)	2010-09-16	2011-09-15	Pochodne dihydrobenzoksatiazepiny, sposób ich wytwarzania i kompozycje farmaceutyczne, które je zawierają, jak również zastosowanie tych związków jako modulatorów receptorów AMPA

Country Status (41)

Country	Link
US (1)	US8569285B2 (pl)
EP (1)	EP2431360B1 (pl)
JP (1)	JP2013537216A (pl)
KR (1)	KR20130054438A (pl)
CN (1)	CN103153973A (pl)
AP (1)	AP2013006793A0 (pl)
AR (1)	AR082973A1 (pl)
AU (1)	AU2011213898A1 (pl)
BR (1)	BR112013005967A2 (pl)
CA (1)	CA2752131C (pl)
CL (1)	CL2013000655A1 (pl)
CO (1)	CO6680709A2 (pl)
CR (1)	CR20130105A (pl)
CU (1)	CU20130037A7 (pl)
CY (1)	CY1114110T1 (pl)
DK (1)	DK2431360T3 (pl)
EA (1)	EA201300340A1 (pl)
EC (1)	ECSP13012489A (pl)
ES (1)	ES2421504T3 (pl)
FR (1)	FR2964969B1 (pl)
GE (1)	GEP20156247B (pl)
GT (1)	GT201300067A (pl)
HR (1)	HRP20130505T1 (pl)
IL (1)	IL225209A0 (pl)
MA (1)	MA34529B1 (pl)
ME (1)	ME01524B (pl)
MX (1)	MX2013002892A (pl)
NI (1)	NI201300028A (pl)
PE (1)	PE20131342A1 (pl)
PH (1)	PH12013500423A1 (pl)
PL (1)	PL2431360T3 (pl)
PT (1)	PT2431360E (pl)
RS (1)	RS52835B (pl)
SA (1)	SA111320755B1 (pl)
SG (1)	SG188380A1 (pl)
SI (1)	SI2431360T1 (pl)
TW (1)	TWI421080B (pl)
UA (1)	UA105320C2 (pl)
UY (1)	UY33574A (pl)
WO (1)	WO2012035216A1 (pl)
ZA (1)	ZA201106353B (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN111559990B (zh) *	2020-05-29	2021-03-09	四川大学华西医院	一种小分子噁噻嗪类衍生物及其应用
CN111518058B (zh) *	2020-05-29	2021-03-09	四川大学华西医院	一种噁噻嗪类化合物及其用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2320354A1 (en) *	1998-02-18	1999-08-26	Neurosearch A/S	Novel compounds and their use as positive ampa receptor modulators
TWI232863B (en) *	2001-06-11	2005-05-21	Akzo Nobel Nv	Benzoxazepine derivatives
JP4435562B2 (ja) *	2001-06-14	2010-03-17	ナームローゼ・フエンノートチヤツプ・オルガノン	（ピリド／チエノ）−［ｆ］−オキサゼピン−５−オン誘導体
FR2856064B1 (fr) *	2003-06-13	2005-08-19	Servier Lab	Nouveaux derives de benzothiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
TW200714597A (en) *	2005-05-27	2007-04-16	Astrazeneca Ab	Chemical compounds

2010
- 2010-09-16 FR FR1003683A patent/FR2964969B1/fr not_active Expired - Fee Related
2011
- 2011-08-24 UY UY0001033574A patent/UY33574A/es unknown
- 2011-08-25 AU AU2011213898A patent/AU2011213898A1/en not_active Abandoned
- 2011-08-30 ZA ZA2011/06353A patent/ZA201106353B/en unknown
- 2011-09-07 CA CA2752131A patent/CA2752131C/fr not_active Expired - Fee Related
- 2011-09-07 TW TW100132314A patent/TWI421080B/zh not_active IP Right Cessation
- 2011-09-14 AR ARP110103332A patent/AR082973A1/es unknown
- 2011-09-14 SA SA111320755A patent/SA111320755B1/ar unknown
- 2011-09-15 EA EA201300340A patent/EA201300340A1/ru unknown
- 2011-09-15 AP AP2013006793A patent/AP2013006793A0/xx unknown
- 2011-09-15 ES ES11290413T patent/ES2421504T3/es active Active
- 2011-09-15 JP JP2013528735A patent/JP2013537216A/ja active Pending
- 2011-09-15 PT PT112904131T patent/PT2431360E/pt unknown
- 2011-09-15 CN CN2011800437978A patent/CN103153973A/zh active Pending
- 2011-09-15 GE GEAP201113048A patent/GEP20156247B/en unknown
- 2011-09-15 SI SI201130030T patent/SI2431360T1/sl unknown
- 2011-09-15 PE PE2013000377A patent/PE20131342A1/es not_active Application Discontinuation
- 2011-09-15 WO PCT/FR2011/000502 patent/WO2012035216A1/fr not_active Ceased
- 2011-09-15 US US13/200,045 patent/US8569285B2/en not_active Expired - Fee Related
- 2011-09-15 BR BR112013005967A patent/BR112013005967A2/pt not_active Application Discontinuation
- 2011-09-15 PH PH1/2013/500423A patent/PH12013500423A1/en unknown
- 2011-09-15 UA UAA201304534A patent/UA105320C2/ru unknown
- 2011-09-15 DK DK11290413.1T patent/DK2431360T3/da active
- 2011-09-15 RS RS20130274A patent/RS52835B/sr unknown
- 2011-09-15 ME MEP-2013-82A patent/ME01524B/me unknown
- 2011-09-15 SG SG2013015904A patent/SG188380A1/en unknown
- 2011-09-15 MA MA35744A patent/MA34529B1/fr unknown
- 2011-09-15 EP EP11290413.1A patent/EP2431360B1/fr active Active
- 2011-09-15 MX MX2013002892A patent/MX2013002892A/es active IP Right Grant
- 2011-09-15 PL PL11290413T patent/PL2431360T3/pl unknown
- 2011-09-15 KR KR1020137009580A patent/KR20130054438A/ko not_active Ceased
2013
- 2013-03-08 CL CL2013000655A patent/CL2013000655A1/es unknown
- 2013-03-11 CR CR20130105A patent/CR20130105A/es unknown
- 2013-03-12 CO CO13049160A patent/CO6680709A2/es not_active Application Discontinuation
- 2013-03-14 CU CU2013000037A patent/CU20130037A7/es unknown
- 2013-03-14 IL IL225209A patent/IL225209A0/en unknown
- 2013-03-14 NI NI201300028A patent/NI201300028A/es unknown
- 2013-03-14 GT GT201300067A patent/GT201300067A/es unknown
- 2013-03-15 EC ECSP13012489 patent/ECSP13012489A/es unknown
- 2013-06-07 HR HRP20130505AT patent/HRP20130505T1/hr unknown
- 2013-07-03 CY CY20131100553T patent/CY1114110T1/el unknown

Also Published As

Publication number	Publication date
TW201212921A (en)	2012-04-01
CA2752131C (fr)	2014-04-22
CA2752131A1 (fr)	2012-03-16
PT2431360E (pt)	2013-05-14
ME01524B (me)	2014-04-20
MX2013002892A (es)	2013-04-10
PE20131342A1 (es)	2013-11-28
AU2011213898A1 (en)	2012-04-05
WO2012035216A1 (fr)	2012-03-22
NI201300028A (es)	2014-01-07
EP2431360A1 (fr)	2012-03-21
PH12013500423A1 (en)	2017-08-23
GEP20156247B (en)	2015-02-10
SG188380A1 (en)	2013-04-30
RS52835B (sr)	2013-10-31
AP2013006793A0 (en)	2013-04-30
ZA201106353B (en)	2012-05-30
DK2431360T3 (da)	2013-07-22
BR112013005967A2 (pt)	2016-05-03
US20120071462A1 (en)	2012-03-22
AR082973A1 (es)	2013-01-23
CL2013000655A1 (es)	2013-08-09
CY1114110T1 (el)	2016-07-27
SA111320755B1 (ar)	2013-11-10
UA105320C2 (ru)	2014-04-25
ES2421504T3 (es)	2013-09-03
IL225209A0 (en)	2013-06-27
MA34529B1 (fr)	2013-09-02
UY33574A (es)	2012-03-30
JP2013537216A (ja)	2013-09-30
EA201300340A1 (ru)	2013-08-30
FR2964969B1 (fr)	2012-08-24
GT201300067A (es)	2014-07-08
CU20130037A7 (es)	2013-05-31
TWI421080B (zh)	2014-01-01
US8569285B2 (en)	2013-10-29
CO6680709A2 (es)	2013-05-31
KR20130054438A (ko)	2013-05-24
FR2964969A1 (fr)	2012-03-23
CN103153973A (zh)	2013-06-12
CR20130105A (es)	2013-05-16
SI2431360T1 (sl)	2013-07-31
EP2431360B1 (fr)	2013-04-17
ECSP13012489A (es)	2013-04-30
HRP20130505T1 (hr)	2013-07-31

Publication	Publication Date	Title
IL266510B (en)	2021-01-31	History of aminopyrimidines, their preparation and pharmaceutical preparations containing them
IL247804B (en)	2018-11-29	Heterocyclic modulators of lipid synthesis, preparations containing them and their uses
IL215178A (en)	2015-01-29	Consolidated derivatives of pyrimidinedione as 1trpa modulators, preparations containing them and their use in the preparation of medicines
IL230218A (en)	2016-12-29	Converted atherothecyclic compounds, their preparations and their pharmaceutical preparations
IL225626A0 (en)	2013-06-27	The history of pyrrolidinone, their preparation and remote preparations containing them
IL231008A (en)	2016-04-21	The history of thiazol, their preparation and their pharmaceutical preparations
IL231009A (en)	2016-09-29	The heterotromatic compounds in the oak, their preparation and their pharmaceutical preparations
IL237839A0 (en)	2015-05-31	History of hydropyrrolopyrrole, their preparation and pharmaceutical preparations containing them
IL235414A (en)	2017-11-30	The history of pyrolotriazinone, their preparation and their pharmaceutical preparations
IL229113A0 (en)	2013-12-31	An[(1h-pyrazol-1-yl)aryl]1h-indole or 1h-indazole-3-carboxamide derivatives, their preparation and use as p2y12 antagonists
PL2562172T3 (pl)	2016-09-30	Pochodne sfelaktonu, ich kompozycje farmaceutyczne, sposoby wytwarzania i zastosowania
IL238825B (en)	2019-10-31	The history of heterocyclics, their preparation and pharmaceutical preparations containing them
ZA201403195B (en)	2020-05-27	Pharmaceutical compositions of hydrophobic camptothecin derivatives
IL232577A (en)	2017-05-29	History of morpholinylbenzotriazine, their preparation and their pharmaceutical preparations
IL226094A0 (en)	2013-06-27	The history of pyrazine, their preparation and pharmaceutical preparations containing them
PL2281822T3 (pl)	2013-06-28	Nowe pochodne dihydroindolonów, sposób ich wytwarzania i zawierające je kompozycje farmaceutyczne
CA2818986A1 (en)	2012-05-31	Indole derivatives as modulators of s1p receptors
IL231383A0 (en)	2014-04-30	History of imidazole amines, their preparation and pharmaceutical preparations containing them
WO2011050054A3 (en)	2011-06-09	Coumarin compounds as receptor modulators with therapeutic utility
IL228019A (en)	2015-11-30	Compounds of histamine 3h receptor antagonists, a process for their preparation and uses
IL230219B (en)	2018-08-30	History of dihydropyrazole, their preparation and pharmaceutical preparations containing them
WO2012071212A3 (en)	2013-04-04	Novel phosphonic acids as s1p receptor modulators
IL225105A (en)	2016-12-29	Heterocyclic compounds, their process, their pharmaceutical preparations and their use in the preparation of drugs
PL2147915T3 (pl)	2011-03-31	Nowe cykloalkilowe pochodne benzotiadiazyn, sposób ich wytwarzania i kompozycje farmaceutyczne zawierające te związki
IL233199A0 (en)	2014-08-03	History of heterocyclic carboxamides, their preparation and pharmaceutical preparations containing them